SLC8A1 and Stroke: Recently, the 103/107 miRNA family has been identified as a possible therapeutic target in stroke, as it is able to determine the downregulation of the member 1 of sodium calcium plasma membrane exchanger family (NCX1), which plays a fundamental role in stroke.6